Simplex Trading
GYRE icon

Simplex Trading’s Gyre Therapeutics GYRE Stock Holding History

Simplex Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-674
Closed -$4.7K – 9683
2026
Q1 		$4.7K Sell
674
-165
-20% -$1.28K ﹤0.01% 7932
2025
Q4 		$5.92K Buy
839
+675
+412% +$5.21K ﹤0.01% 7334
2025
Q3 		$1K Buy
+164
New +$1.25K ﹤0.01% 8812
2023
Q2 		– Sell
-2,962
Closed -$10.6K – 9340
2023
Q1 		$9K Buy
+2,962
New +$11.3K ﹤0.01% 7621
2022
Q1 		– Sell
-306
Closed -$1.52K – 10774
2021
Q4 		$2K Buy
+306
New +$5.23K ﹤0.01% 9992
2020
Q3 		– Sell
-4,101
Closed -$161K – 8060
2020
Q2 		$180K Sell
4,101
-670
-14% -$31.5K ﹤0.01% 4110
2020
Q1 		$156K Buy
4,771
+3,968
+494% +$182K ﹤0.01% 3876
2019
Q4 		$41K Sell
803
-8
-1% -$335 ﹤0.01% 5375
2019
Q3 		$29K Sell
811
-1,081
-57% -$58.3K ﹤0.01% 5517
2019
Q2 		$104K Sell
1,892
-1,026
-35% -$64.1K ﹤0.01% 4146
2019
Q1 		$177K Sell
2,918
-798
-21% -$51.3K ﹤0.01% 3739
2018
Q4 		$219K Buy
3,716
+3,150
+557% +$232K ﹤0.01% 3077
2018
Q3 		$45K Sell
566
-5,066
-90% -$401K ﹤0.01% 5265
2018
Q2 		$492K Buy
5,632
+3,952
+235% +$693K ﹤0.01% 2473
2018
Q1 		$325K Buy
+1,680
New +$313K 0.01% 953
2017
Q2 		– Sell
-2,216
Closed -$156K – 6361
2017
Q1 		$156K Buy
+2,216
New +$129K 0.01% 1408
2015
Q3 		– Sell
-1
Closed -$1K – 5758
2015
Q2 		$1K Hold
1
– – ﹤0.01% 4662
2015
Q1 		$1K Buy
+1
New +$2.07K ﹤0.01% 4480

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's GYRE Position: Q2 2026 in Review

Simplex Trading sold out of Gyre Therapeutics (GYRE) in Q2 2026, closing a stake of 674 shares — an estimated $4.7K sold.

Simplex Trading first reported a position in GYRE in Q1 2015 and held it in 18 quarters. The position peaked at $492K in Q2 2018. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Simplex Trading reported no remaining Gyre Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 674 Gyre Therapeutics shares in Q2 2026, an estimated $4.7K.
  • Simplex Trading first reported a position in Gyre Therapeutics in Q1 2015 and held it in 18 quarters.
  • Simplex Trading's Gyre Therapeutics position peaked at $492K in Q2 2018.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.